-
61
Hepatoprotection by L-Ornithine L-Aspartate in Non-Alcoholic Fatty Liver Disease
Published 2019-03-01Subjects: Get full text
Article -
62
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
Published 2025-03-01Subjects: Get full text
Article -
63
Correlation between metabolic dysfunction-associated steatotic liver disease and subclinical coronary atherosclerosis in eastern China
Published 2025-01-01Subjects: “…Non-alcoholic fatty liver disease…”
Get full text
Article -
64
The value of sex hormones and sex hormone-binding globulin in metabolic dysfunction-associated fatty liver disease among boys with obesity
Published 2025-02-01Subjects: Get full text
Article -
65
Non-invasive methods for diagnosing portal hypertension and variceal bleeding due to liver cirrhosis secondary to NAFLD/MASLD: systematic review
Published 2025-01-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article -
66
The rationale for the aggressive progression of MASLD in patients with type 2 diabetes
Published 2025-01-01Subjects: Get full text
Article -
67
A soy glycinin derived octapeptide protects against MCD diet induced non-alcoholic fatty liver disease in mice
Published 2022-11-01Subjects: Get full text
Article -
68
Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
Published 2024-05-01Subjects: Get full text
Article -
69
Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
Published 2024-12-01Subjects: “…non-alcoholic fatty liver disease…”
Get full text
Article